CClinicalTrials.gg
RecruitingNCT07635719Updated Sep 29, 2026

Coblator Wand Comparative Analysis

An interventional study of New Coblator Ablation Wands and Reprocessed Medline Coblator Ablation Wands in Tonsillectomy and Adenoidectomy, sponsored by Montefiore Medical Center. Recruiting at 1 site in United States. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Montefiore Medical Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
1 Year to 18 Years
Sex
All
01

Study summary

This study will address the gap in coblator wands by comparing the performance of reprocessed coblator wands with new wands in terms of efficiency and technical issues. As part of the evaluation, the investigator team will conduct the technical performance of the life cycle assessment of reprocessed versus new coblation wands based on the methodology described in the literature (see References) in studies of laryngoscopes.

Read the detailed description

Reprocessed operating room tools offer surgeons an opportunity to use equipment that have been inferenced to incur lower hospital and environmental costs. Tools that are "disposable" are collected by reprocessing companies that then refurbish and sterilize the instrument and sell it back to the hospital at a reduced cost. Advocates argue that they may serve as a means of controlling increasing healthcare costs and further, because few if any new raw materials are needed for the reprocessing, environmental costs are also hypothesized to be reduced. However, the use of reprocessed tools has demonstrated variable results in clinical performance across different surgical domains. Comparable performance of reprocessed orthopedic drill bits to new ones in terms of force, heat, and usability has been demonstrated (see References). It has been shown that blinded surgeons could not distinguish between new and reprocessed arthroscopic shavers and found equivalent sharpness on engineering tests. In contrast, it has been found that reprocessed laparoscopic trocars had more imperfections and higher leak rates (see References) reported more abnormalities in reprocessed harmonic scalpels with poorer tissue handling outcomes. There remains a lack of consensus about the reliability of reprocessed surgical tools, including coblator wands.

02

Conditions studied

  • Tonsillectomy
  • Adenoidectomy

Keywords

  • Coblator wand
  • Product performance
  • Usability
03

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric patients scheduled for tonsillectomy and/or adenoidectomy
  • Parental consent and child assent (when applicable)

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    New Coblator Ablation Wands

    Device: New Coblator Ablation Wands

  • Active comparator
    Reprocessed Coblator Ablation Wands

    Device: Reprocessed Medline Coblator Ablation Wands

Interventions

  • DeviceNew Coblator Ablation Wands

    New, unused coblator ablation wands from Arthrocare

    Also known as: Coblator II EVac 70 Plasma Wand

  • DeviceReprocessed Medline Coblator Ablation Wands

    Reprocessed coblator ablation wands from Medline

    Also known as: ReNewal Reprocessed Arthrocare Ablation Wand

05

What researchers measure

Primary outcomes

  1. Surgeon Comfort

    The primary outcome for this study is surgeon comfort in terms of using the new or reprocessed coblator wand again based on data collected from the post-procedure surveys. Surgeon comfort will be assessed as a dichotomous (yes/no) measure following the procedure. The number of instances for which the surgeon is comfortable using the new or reprocessed coblator wand will be summarized by study arm using descriptive statistics.

    Time frame: Following the procedure, up to 4 hours

06

Study locations

1 of 1 sites recruiting
07

References and documents

Publications

  • Myers R, Kim H, Hsieh AH, O'Toole RV, Sciadini MF. When Should We Change Drill Bits? A Mechanical Comparison of New, Reprocessed, and Damaged Bits. J Orthop Trauma. 2017 May;31(5):281-286. doi: 10.1097/BOT.0000000000000812. PubMed 28166171 ↗
  • Ledonio CG, Arendt EA, Adams JE, Matz J, Boers A, Miller K, Lester BR. Reprocessed arthroscopic shavers: evaluation of sharpness and function in a cadaver model. Orthopedics. 2014 Jan;37(1):e1-9. doi: 10.3928/01477447-20131219-09. PubMed 24683649 ↗
  • Mues AC, Haramis G, Casazza C, Okhunov Z, Badani KK, Landman J. Prospective randomized single-blinded in vitro and ex vivo evaluation of new and reprocessed laparoscopic trocars. J Am Coll Surg. 2010 Dec;211(6):738-43. doi: 10.1016/j.jamcollsurg.2010.08.003. Epub 2010 Oct 30. PubMed 21036630 ↗
  • Weld KJ, Dryer S, Hruby G, Ames CD, Venkatesh R, Matthews BD, Landman J. Comparison of mechanical and in vivo performance of new and reprocessed harmonic scalpels. Urology. 2006 May;67(5):898-903. doi: 10.1016/j.urology.2005.11.027. PubMed 16698349 ↗
  • Jin T, Huang W, Jiang K, Xiong JJ, Xue P, Javed MA, Yang XN, Xia Q. Urinary trypsinogen-2 for diagnosing acute pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):355-62. doi: 10.1016/s1499-3872(13)60056-9. PubMed 23924492 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT07635719
Lead sponsor
Montefiore Medical Center
Responsible party
Sponsor
First posted
Jun 9, 2026
Start date
Oct 2026 (estimated)
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Hannah Collins
Contact
hannah.collins@einsteinmed.edu
914-705-3215
Salma Ahsanuddin, MD
Contact
sahsanuddi@montefiore.org
John Bent, MD
principal investigator · Montefiore Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion